New Pathways to Neuroscience Breakthroughs
Brain-based illnesses and injuries are the leading cause of disability worldwide. However, medical professionals lack the tools needed to diagnose and treat illnesses ranging from Alzheimer's disease to post-traumatic stress disorder (PTSD). Gaining traction in this vast field will not only require targeted research funding, but potentially also a change in the way the brain is studied. Policy makers, funders, industry experts, and researchers will discuss how the field of neuroscience research will need to adapt and the specific role of public-, private-, and philanthropic-research funding required to accomplish the audacious but necessary goal of curing brain-disease.
Moderator
Rick Berke
Co-Founder and Executive Editor, STAT
Speakers
Cara Altimus
Director, Center for Strategic Philanthropy, Milken Institute
Jeffrey Borenstein
President and CEO, Brain & Behavior Research Foundation
Niranjan Bose
Managing Director, Health and Life Sciences, Gates Ventures
Johannes Streffer
Vice President and Head of Translational Medicine Neuroscience, Early Solutions, UCB Biopharm
